ImmunoPrecise to Present at the Benchmark Company’s Discovery One-on-One Virtual Video Investor Conference on Thursday December 2, 2021
11/24/2021 - 08:02 AM
VICTORIA, British Columbia --(BUSINESS WIRE)--
IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (NASDAQ: IPA) (TSX VENTURE: IPA) is presenting at the Benchmark Company’s Discovery One-on-One Virtual Video Investor Conference . The conference is being held on December 2 nd , 2021.
About the Benchmark Company & Discovery One on One Virtual Video Investor Conference 2021. The Benchmark Company, LLC , is a diversified financial services firm that offers a full suite of investment banking and institutional brokerage services. We were founded in 1988 and headquartered in New York City with offices in San Francisco , Boston , and Milwaukee . Our focus is fostering the long-term success of our corporate clients through raising capital, providing strategic advisory services, generating insightful and actionable research, and developing institutional sponsorship by leveraging the firm’s sales, trading, and equity research capabilities.
Benchmark’s Discovery One-on-One Virtual Video Investor Conference
To register for the conference please contact:
Vince Curatola – Director of Corporate Marketing Services
vcuratola@benchmarkcompany.com
About ImmunoPrecise Antibodies Ltd
ImmunoPrecise is an innovation-driven technology platform company that supports its business partners in their quest to discover and develop novel antibodies against a broad range of classes of disease targets. The Company endeavors to transform the conventional multi-vendor antibody discovery model by providing a comprehensive suite of services tailored to optimize antibody genetic diversity and epitope coverage, to discover antibodies against rare and/or challenging epitopes.
For further information, visit www.immunoprecise.com .
View source version on businesswire.com : https://www.businesswire.com/news/home/20211124005866/en/
IPA investor contact:
LifeSci Advisors
John Mullaly
jmullaly@lifesciadvisors.com
Source: ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd
NASDAQ:IPA
IPA Rankings
#4989 Ranked by Stock Gains
IPA Stock Data
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Country
Canada
City
Victoria
About IPA
immunoprecise antibodies is a highly specialized customer focused life sciences company that provides custom antibody development and immunology services from its headquarters in beautiful victoria, bc, canada. our dedication to advancing antibody development has resulted in cutting-edge immunological innovations such as single-step cloning, rapid prime immunization strategies, and recombinant monoclonal technology. we pride ourselves on our high customer satisfaction and our clients have grown accustomed to receiving thorough and professional service. we customize your project to generate antibodies that meet your specific needs. over our 20+ year history, we have gained the trust of a diverse group of customers that include research agencies, universities, biotechnology and pharmaceutical companies of all sizes from around the globe. immunoprecise is pleased to announce its newest line of services, immunoprotect™. with immunoprotect™, the dna sequence of your mab is determined and ca
